COMBINED DRUGS FOR THERAPY OF OSTEOARTHROSIS, EFFECTIVENESS OF THERAFLEX
OA is the most frequent form of joints and the chief reason of disease incidence and incapacity to work. Considerable increase of disease incidence is predetermined by quick ageing of population and obesity pandemic. Major clinical symptoms of OA are joints pain and deformation leading to functional insufficiency. Treatment of OA requires not only accurate diagnostics but evaluation of the incidence rate and gravity of the joint process, general status of the patient and presence of concomitant diseases for the correct choice of the therapy method, as well as their combination. The proved effectiveness of chondroitin sulfate and glucosamine hydrochloride as monotherapy created the basis for development of combined drugs. The effectiveness of this combination is confirmed by experimental and clinical data.